Humana Inc. (HUM)
HUM trades on NYSE in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$420.38
-3.03% on the day
Market cap
$50.5B
Large cap
Revenue · 2025
$129.7B
+10.1% on 2024
Net income · 2025
$1.2B
0.9% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | HUM on NYSE |
| Sector | Health Care |
| Industry | Medical Specialities |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000049071 |
| SEC industry code | Hospital & Medical Service Plans |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $129.7B |
| Net income | $1.2B |
| Operating income | $2.7B |
| Net margin | 0.9% |
| Operating margin | 2.1% |
| Revenue growth | +10.1% |
| Cash | $4.2B |
| Total assets | $48.9B |
| P/E (computed) | 42.5× |
| P/S (computed) | 0.4× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-03-06 |
| Latest annual report | 10-K | 2026-02-19 |
| Latest quarterly / interim | 10-Q | 2026-07-29 |
| Latest current report | 8-K | 2026-10-13 |
| Latest proxy | DEFA14A | 2026-03-06 |
Source: SEC EDGAR submissions feed, 1,003 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +7.8% |
| 1 month | +7.8% |
| 3 months | +10.6% |
| Year to date | +66.9% |
| 1 year | +57.7% |
| From 52-week high | -1.4% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical Specialities
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NTRA | Natera Inc. | $395.65 | -0.53% | $57.0B |
| ILMN | Illumina Inc. | $271.18 | -1.99% | $40.9B |
| CI | The Cigna Group | $282.53 | -0.29% | $74.7B |
| CNC | Centene Corporation | $68.86 | +2.75% | $34.0B |
| ELV | Elevance Health Inc. | $425.27 | +0.75% | $92.2B |
| DGX | Quest Diagnostics Incorporated | $230.46 | -0.93% | $25.4B |
| LH | Labcorp Holdings Inc. | $313.64 | -0.60% | $25.4B |
| GH | Guardant Health Inc. | $162.09 | -0.43% | $21.8B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier